NPM1 and acute myeloid leukemia: Recently, we have characterized that NPM1 stimulates APE1 BER activity and, most importantly, AML patients bearing NPMc+ were more responsive to chemotherapy, due to the consequent APE1 accumulation into the cytoplasm [13].